Landmark 1,000-Patient Registry Trial Opens: Cardiac MRI Biomarkers and Mortality Prediction in Duchenne, Becker and Carrier Cardiomyopathy — What Clinicians Need to Know
247 Health News Editorial
·16 July 2026
·5 min read
·clinical-trialsA landmark 1,000-patient registry study at Vanderbilt University Medical Center is recruiting patients with Duchenne muscular dystrophy, Becker muscular dystrophy, and dystrophin gene carriers to map the natural history of dystrophin-associated cardiomyopathy using advanced cardiac MRI and deep learning analysis. The study aims to develop a globally accessible risk prediction toolkit and validate CMR-derived surrogate endpoints for future therapeutic trials, addressing one of the most critical unmet needs in neuromuscular medicine.
Originally reported by ClinicalTrials.gov
References
- 1.Vanderbilt University Medical Center. (2025). Evaluating cardiac function in patients with Duchenne muscular dystrophy (NCT07674758). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07674758
- 2.Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., Tsuda, T., Wang, P. J., & Yoo, S. J. (2017). Management of cardiac involvement associated with neuromuscular diseases: A scientific statement from the American Heart Association. Circulation, 136(13), e200–e231. https://doi.org/10.1161/CIR.0000000000000526
- 3.Kamdar, F., & Garry, D. J. (2016). Dystrophin-deficient cardiomyopathy. Journal of the American College of Cardiology, 67(21), 2533–2546. https://doi.org/10.1016/j.jacc.2016.02.081
- 4.Soslow, J. H., Damon, B. M., Saville, B. R., Xu, M., Slaughter, J. C., Jefferies, J. L., Parra, D. A., Sawyer, D. B., & Markham, L. W. (2015). Evaluation of myocardial fibrosis in Duchenne muscular dystrophy using cardiac magnetic resonance imaging-based feature tracking and myocardial strain. Pediatric Cardiology, 36(3), 561–567. https://doi.org/10.1007/s00246-015-1139-8
- 5.Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., Street, N., Tomezsko, J., & Wagner, K. R. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology, 17(4), 347–361. https://doi.org/10.1016/S1474-4422(18)30025-5
- 6.Holloway, S. M., Wilcox, D. E., Wilcox, A., Dean, J. C., Berg, J. N., Goudie, D. R., Denvir, M. A., & Porteous, M. E. (2008). Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart, 94(5), 633–636. https://doi.org/10.1136/hrt.2007.116947
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service